ArticleBritish journal of cancer2016

Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patients.

Angelica Loskog et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.